J. H. Law

Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma

M. Chua, Fei-Fei Liu, W. Shi, 2018, Oncogenesis.

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma

S. Tsao, Fei-Fei Liu, W. Shi, 2019, BMC Cancer.

Editorial: Hallmark of cancer: Resisting cell death

Yichao Zhu, Qiang Sun, K. Yip, 2022, Frontiers in Oncology.

A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer.

T. Stockley, E. Chen, D. Graham, 2021, Lung cancer.